Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGXT | P21549 | 1/20 | 0.47 |
| ▸ | BCL2 | P10415 | 1/20 | 0.45 |
| ▸ | PTGES | O14684 | 1/20 | 0.44 |
| ▸ | AOC3 | Q16853 | 3/20 | 0.44 |
| ▸ | FAAH | O00519 | 1/20 | 0.43 |
| ▸ | NAAA | Q02083 | 1/20 | 0.43 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.42 |
| ▸ | PRKCI | P41743 | 1/20 | 0.42 |
| ▸ | SHMT1 | P34896 | 1/20 | 0.41 |
| ▸ | SHMT2 | P34897 | 1/20 | 0.41 |
| ▸ | IDH1 | O75874 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.41 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.40 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.40 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.40 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.40 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.40 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.40 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.40 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28206743 | 0.84 | AGXT (0.50) | AGXTBCL2PTGESAOC3FAAH | |
| SCHEMBL20262937 | 0.83 | SLC7A5 (0.39) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL28977318 | 0.82 | LMNA (0.57) | AGXT | |
| SCHEMBL531194 | 0.81 | CES1 (0.50) | — | |
| SCHEMBL11339635 | 0.81 | CES1 (0.50) | — | |
| Benzene SCHEMBL9806260 | 0.81 | CES1 (0.50) | — | |
| SCHEMBL15214656 | 0.81 | BCL2 (0.53) | AGXTBCL2PTGESAOC3FAAH | |
| SCHEMBL14565973 | 0.80 | AGXT (0.47) | AGXTBCL2PTGESAOC3FAAH | |
| SCHEMBL27842022 | 0.79 | PRKCI (0.47) | AGXTBCL2AOC3FAAHNAAA | |
| SCHEMBL2302646 | 0.79 | BCL2 (0.56) | AGXTBCL2PTGESAOC3FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2006047158-A2 | NOVEL COMPOSITIONS OF MONOMERS, OLIGOMERS AND POLYMERS AND METHODS FOR MAKING THE SAME | HOKU SCIENTIFIC, INC. (US) | 2006-05-04 | — | — | WO | disclosed |
| WO-2006047329-A2 | NOVEL COMPOSITIONS OF MONOMERS, OLIGOMERS AND POLYMERS AND METHODS FOR MAKING THE SAME | HOKU SCIENTIFIC, INC. (US) | 2006-05-04 | — | — | WO | disclosed |
| WO-2006047157-A2 | NOVEL COMPOSITIONS OF MONOMERS, OLIGOMERS AND POLYMERS AND METHODS FOR MAKING THE SAME | HOKU SCIENTIFIC, INC. (US) | 2006-05-04 | — | — | WO | disclosed |
| US-20060089510-A1 | Novel compositions of monomers, oligomers and polymers and methods for making the same | HOKU SCIENTIFIC, INC. - A DELAWARE CORPORATION | 2006-04-27 | — | — | US | disclosed |
| US-20060088748-A1 | Novel compositions of monomers, oligomers and polymers and methods for making the same | HOKU SCIENTIFIC, INC. - A DELAWARE CORPORATION | 2006-04-27 | — | — | US | disclosed |
| US-20060088749-A1 | Novel compositions of monomers, oligomers and polymers and methods for making the same | HOKU SCIENTIFIC, INC. - A DELAWARE CORPORATION | 2006-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060089510-A1 | Novel compositions of monomers, oligomers and polymers and methods for making the same | SMC2, SMC3, SMC4 | AGXT 4159/4885BCL2 3069/4885PTGES 4059/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.